Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP528637.RASLSM7bllo6cUI9pP_vFzmRVIyQSEK5cpueXofVQ6ZKs130_assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528637.RASLSM7bllo6cUI9pP_vFzmRVIyQSEK5cpueXofVQ6ZKs130_provenance.
• assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP183388.RAk-Ed3Nj2TFBXMfPwmsAFhkT4qFJXG46FozOVPp1niB8130_assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183388.RAk-Ed3Nj2TFBXMfPwmsAFhkT4qFJXG46FozOVPp1niB8130_provenance.
• NP162512.RAFm0lnpNspQYwdFaUtq4L9hMpaFKoCEM1LNfKv1BGdhw130_assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162512.RAFm0lnpNspQYwdFaUtq4L9hMpaFKoCEM1LNfKv1BGdhw130_provenance.
• assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP311597.RAEvZBZvD2oE7VUt7eP8_tcKs1ojfcxZ7znz4CBsZGatQ130_assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311597.RAEvZBZvD2oE7VUt7eP8_tcKs1ojfcxZ7znz4CBsZGatQ130_provenance.
• NP886740.RAxPDb6PIvilYTFLB-pf4CuWFHxpLM92JElDqkElvfJEE130_assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP886740.RAxPDb6PIvilYTFLB-pf4CuWFHxpLM92JElDqkElvfJEE130_provenance.
• NP904269.RAznL5Q_JZoiajK6GS-FCKYTc9TYaqF8ATD46dyYVRSXc130_assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904269.RAznL5Q_JZoiajK6GS-FCKYTc9TYaqF8ATD46dyYVRSXc130_provenance.
• NP748770.RAbT-bz5wCHjmFvFkM08ImMgka2C_LRB7lRA8vuibGvDI130_assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748770.RAbT-bz5wCHjmFvFkM08ImMgka2C_LRB7lRA8vuibGvDI130_provenance.
• NP348811.RAy6tNxRo5-Z8pZMkMIx5p1fGLT17ssDNnAnqfPeRoh8A130_assertion description "[The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348811.RAy6tNxRo5-Z8pZMkMIx5p1fGLT17ssDNnAnqfPeRoh8A130_provenance.